Adicet Bio, Inc. Operating Lease, Payments
Adicet Bio, Inc. (ACET) reported Operating Lease, Payments of $100.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-05
- Adicet Bio, Inc. operating lease, payments for the quarter ending 2026-06-30 was -$200.00K.
- Adicet Bio, Inc. operating lease, payments for the quarter ending 2026-03-31 was $300.00K, a 66.67% decline year-over-year.
- Adicet Bio, Inc. operating lease, payments for the quarter ending 2025-12-31 was -$200.00K.
- Adicet Bio, Inc. operating lease, payments for the quarter ending 2025-09-30 was -$100.00K.
- Adicet Bio, Inc. operating lease, payments for fiscal 2025 was $400.00K, a 60.00% decline from fiscal 2024.
- Adicet Bio, Inc. operating lease, payments for fiscal 2024 was $1.00M, a 41.18% decline from fiscal 2023.
- Adicet Bio, Inc. operating lease, payments for fiscal 2023 was $1.70M.
- Adicet Bio, Inc. operating lease, payments for fiscal 2020 was $3.17M, a 352.57% increase from fiscal 2019.
| Period end | Operating Lease, Payments 1 month | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $100.00K 10-Q · filed 2026-08-05 | -$100.00K derived: sum of 3 quarters · filed 2026-08-05 | -$200.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-13 | $100.00K derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | -$200.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2025-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$300.00K derived: sum of 2 quarters · filed 2026-03-12 | -$500.00K derived: sum of 3 quarters · filed 2026-03-12 | $400.00K 10-K · filed 2026-03-12 | ||
| 2025-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$300.00K derived: sum of 2 quarters · filed 2025-11-05 | $600.00K 10-Q · filed 2025-11-05 | $400.00K derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2025-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $700.00K 10-Q · filed 2025-08-07 | $500.00K derived: sum of 3 quarters · filed 2025-08-07 | $300.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2025-03-31 | $900.00K 10-Q · filed 2025-05-06 | $700.00K derived: sum of 2 quarters · filed 2025-05-06 | $500.00K derived: sum of 3 quarters · filed 2025-05-06 | $400.00K derived: sum of 4 quarters · filed 2025-05-06 | ||
| 2024-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$400.00K derived: sum of 2 quarters · filed 2025-03-06 | -$500.00K derived: sum of 3 quarters · filed 2025-03-06 | $1.00M 10-K · filed 2025-03-06 | ||
| 2024-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$300.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.20M 10-Q · filed 2024-11-06 | $1.10M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2024-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.40M 10-Q · filed 2024-08-13 | $1.30M derived: sum of 3 quarters · filed 2024-08-13 | $1.10M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2024-03-31 | $1.50M 10-Q · filed 2024-05-14 | $1.40M derived: sum of 2 quarters · filed 2024-05-14 | $1.20M derived: sum of 3 quarters · filed 2024-05-14 | $1.00M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2023-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$300.00K derived: sum of 2 quarters · filed 2024-03-19 | -$500.00K derived: sum of 3 quarters · filed 2024-03-19 | $1.70M 10-K · filed 2024-03-19 | ||
| 2023-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$400.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.80M 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.00M 10-Q · filed 2023-08-09 | ||||
| 2023-03-31 | $2.20M 10-Q · filed 2023-05-09 | |||||
| 2020-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.77M derived: sum of 2 quarters · filed 2021-03-12 | $3.17M 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-05 | $600.00K 10-Q · filed 2020-11-05 | ||||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $400.00K derived: sum of 2 quarters · filed 2021-03-12 | $700.00K 10-K · filed 2021-03-12 | $500.00K 10-K · filed 2020-03-12 | ||
| 2019-09-30 | $200.00K 10-Q · filed 2020-11-05 | $500.00K 10-Q · filed 2020-11-05 | ||||
| 2019-04-30 | $3.50M 10-K · filed 2021-03-12 | |||||
| 2018-12-31 | $500.00K 10-K · filed 2021-03-12 | $200.00K 10-K · filed 2019-03-18 | ||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |